Pharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in PregnancyClinical and Translational Science
AbstractTo address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration’s role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist’s role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.
Originally published by Wiley under a Creative Commons Attribution Non-Commercial-NoDerivs License in Clinical and Translational Science, 2011, Volume 4, Issue 3. DOI: 10.1111/j.1752-8062.2011.00280.x.
Citation InformationDavid M. Haas, Beverly Gallauresi, Kristine Shields, Deborah S. Zeitlin, et al.. "Pharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy" Clinical and Translational Science Vol. 4 Iss. 3 (2011) p. 204 - 209
Available at: http://works.bepress.com/deborah-zeitlin/9/